Healthy Choices to Promote Health and Reduce Risk in HIV-Infected Youth
NCT ID: NCT00103532
Last Updated: 2019-03-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
225 participants
INTERVENTIONAL
2005-03-31
2008-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Aim of This Study is to Determine the Effectiveness of a Motivational Enhancement Intervention in Reducing Risk Behaviors (Drug and Alcohol Use, Sexual Risk Behavior, Poor Adherence to Medications) Among HIV+ Youth. - 1
NCT00227825
Comparing the Effectiveness of Two Alcohol+Adherence Interventions for HIV+ Youth
NCT01969461
Motivating HIV+ Women: Risk Reduction and ART Adherence
NCT00253045
Intervention Development for Newly Diagnosed Youth With HIV
NCT00255892
Behavioral Intervention Trial for HIV-infected Injection Drug Users
NCT00146445
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Randomization procedures will take place after completion of the baseline assessment. Participants who are randomized to the intervention group will participate in four sessions for approximately 3 months and will also receive standard care plus individualized referrals. The control group will receive standard care and individualized referrals. All five sites offer comprehensive, multidisciplinary care including social work and case management services and access to mental health services. Participants will receive a three-month post-test designed to coincide with ME completion. Subsequent post-tests will occur at 6, 9, 12, and 15 months after baseline data collection (3, 6, 9, and 12 months after ME completion).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy Choices - Motivational Enhancement Intervention
Motivational enhancement intervention
Healthy Choices - Motivational Enhancement Intervention
Participants who are randomized to the intervention group will participate in four sessions (over approximately 3 months) of Healthy Choices; a motivational enhancement intervention specifically designed to target multiple risk behaviors in HIV+ youth. Participants will receive individualized referrals at the fourth session.
Standard Care
Standard care/individualized referrals
Standard care
Participants will receive standard care plus referrals at three months post-baseline
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Healthy Choices - Motivational Enhancement Intervention
Participants who are randomized to the intervention group will participate in four sessions (over approximately 3 months) of Healthy Choices; a motivational enhancement intervention specifically designed to target multiple risk behaviors in HIV+ youth. Participants will receive individualized referrals at the fourth session.
Standard care
Participants will receive standard care plus referrals at three months post-baseline
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Males or females between the age of 16 years and 0 days and 24 years and 364 days at the time of study enrollment.
* Reports having ever engaged in at least 2 of the following 3 behaviors based on screening questionnaire:
* taken prescribed antiretroviral medications, OR been told by his/her physician that he/she should be on antiretroviral medications (whether he/she takes them or not);
* vaginal or anal sex, OR
* alcohol or drug use.
* At least one of the 3 aforementioned behaviors are currently at a problem level, based on screening questionnaire:
* taking currently prescribed antiretroviral medications \<90 % of the time in the last month,
* having unprotected intercourse within the last 3 months,
* demonstrating problem level alcohol and/or drug use as measured during screening.
* Able to understand spoken and written English sufficiently to provide consent/assent and be interviewed and participate in study intervention.
* Not intending to relocate out of the current geographical area for the duration of study participation.
Exclusion Criteria
* Currently involved in behavioral research (assessment or intervention) targeting adherence, sexual risk, or alcohol and/or drug substance abuse OR currently involved in a substance abuse treatment program.
16 Years
24 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Drug Abuse (NIDA)
NIH
National Institute of Mental Health (NIMH)
NIH
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
NIH
University of North Carolina, Chapel Hill
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sylvie Naar-King, PhD
Role: STUDY_CHAIR
Children's Hospital of Michigan
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Children's Hospital of Los Angeles
Los Angeles, California, United States
University of Southern California
Los Angeles, California, United States
Children's Diagnostic and Teatment Center
Fort Lauderdale, Florida, United States
University of Maryland
Baltimore, Maryland, United States
Children's Hospital of Michigan
Detroit, Michigan, United States
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Naar-King S, Parsons JT, Murphy DA, Chen X, Harris DR, Belzer ME. Improving health outcomes for youth living with the human immunodeficiency virus: a multisite randomized trial of a motivational intervention targeting multiple risk behaviors. Arch Pediatr Adolesc Med. 2009 Dec;163(12):1092-8. doi: 10.1001/archpediatrics.2009.212.
Related Links
Access external resources that provide additional context or updates about the study.
description of the Adolescent Trials Network and contact information
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ATN 004
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.